Align Technology (ALGN) Stock Price, Fundamentals & Analysis

What ALGN does

Align Technology (ALGN) designs and sells clear aligners, retainers, and intraoral scanners. Its main product is the Invisalign system, which includes comprehensive treatment packages for adults and teens, as well as phased options for younger patients. The company also offers training tools, whitening systems, and 3D printing solutions for dental professionals.

Key numbers explained

• 148.17 USD is the latest trading price, which is part of the S&P 500.
• The trailing P/E ratio of 25.7 divides the current share price by the last twelve months of earnings, showing how much investors pay per dollar of recent earnings.
• The forward P/E ratio of 11.8 uses expected future earnings, often making it easier to compare growth prospects across companies like Zimmer Biomet (ZBH) or Medtronic (MDT).
• A dividend yield of 0% means the company does not pay a cash dividend to shareholders.
• The beta of 1.64 suggests the stock tends to move about 64% more than the overall market, indicating higher volatility.
• Revenue of 4.14 mld. USD and profitMargin of 10% show the scale of sales and the share that turns into net profit.
• The 52-week range of 122 – 200.44 and a one-year price change of 19.6% place the current price within its recent trading history.

Recent news

Headlines highlight that ALGN is among stocks analysts consider worth attention, while others question its performance relative to the healthcare sector. Recent coverage also discusses the company's Invisalign growth runway amid broader consumer headwinds.

What to watch

Investors typically monitor new product launches, regulatory changes for medical devices, and consumer demand for orthodontic treatments. Competitive dynamics within the medical instruments space and broader healthcare policy shifts can also influence the stock. For context on peers, see Amgen (AMGN), Elevance Health (ELV), and Bristol Myers Squibb (BMY).